Nanobody-based bioPROTAC for viral protein degradation provides an antiviral strategy for porcine arterivirus
{{output}}
Background: Proteolysis-targeting chimeras (PROTACs) are powerful tools for targeted protein degradation and are expected to contribute to a promising strategy for next-generation precision therapeutic antiviral drug development.... ...
